Claims
- 1. A composition that induces synthesis of stress protective proteins during application of physical or physiological stresses, or physiopathological aggressions on cells comprising a water-alcohol extract of red algae, taurine and derivatives: about 1 to about 5%, floridoside and derivatives: about 10 to about 25%, one or more of carotenoids and PUFAs, one or more water-soluble vitamins, one or more free amino acids and derivatives, and pigments.
- 2. The composition according to claim 1, wherein the red algae belongs to species Porphyra umbilicalis.
- 3. The composition according to claim 1, wherein the red algae extract comprises from about 1 to about 30% by weight of the total weight of the composition.
- 4. The composition according to claim 3, wherein the red algae extract comprises from about 15 to about 25% by weight of the total weight of the product.
- 5. The composition according to claim 4, further comprising maltodextrins.
- 6. The composition according to claim 4, further comprising glycerol.
- 7. The composition according to claim 1, further comprising a preservative agent and subjected to sterilizing filtration (0.2μ).
- 8. A method of protecting skin against wrinkle formation comprising administering a therapeutically effective amount of a composition comprising a water-alcohol extract of red algae that induces synthesis of stress protective proteins during physical or physiological stresses, or physiopathological aggressions on skin cells.
- 9. The method according to claim 8, wherein the red algae belongs to species Porphyra umbilicalis.
- 10. The method according to claim 8, wherein the algae extract comprises:
taurine and derivatives: about 1 to about 5%, floridoside and derivatives: about 10 to about 25%, one or more carotenoids and PUFAs, one or more water-soluble vitamins, one or more free amino acids and derivatives, and one or more pigments.
- 11. The method according to claim 8, wherein the red algae extract comprises from about 1 to about 30% by weight of the total weight of the composition.
- 12. The method according to claim 11, wherein the red algae extract comprises from about 15 to about 25% by weight of the total weight of the composition.
- 13. The method according to claim 12, wherein the composition further comprises maltodextrins.
- 14. The method according to claim 12, wherein the composition further comprises glycerol.
- 15. The method according to claim 14, wherein the composition further comprises a preservative agent and is subjected to a sterilizing filtration (0.2μ).
- 16. The method according to claim 8, wherein the composition provides from about 10 to about 1000 mg of the extract per administration.
- 17. The method according to claim 8, wherein the composition comprises from about 0.1 to about 5% by weight of the extract.
- 18. The method according to claim 8, wherein the stress protective proteins are selected from the group consisting of HSP60, HSP70 and HSP27.
- 19. The method according to claim 8, wherein the composition is topically or orally administered.
- 20. A method of inducing synthesis of stress protective proteins in skin comprising administering a therapeutically effective amount of a composition comprising a water-alcohol extract of red algae to a patient.
- 21. The method according to claim 20, wherein the red algae belongs to species Porphyra umbilicalis.
- 22. The method according to claim 20, wherein the algae extract comprises:
taurine and derivatives: about 1 to about 5%, floridoside and derivatives: about 10 to about 25%, one or more carotenoids and PUFAs, one or more water-soluble vitamins, one or more free amino acids and derivatives, and one or more pigments.
- 23. The method according to claim 20, wherein the red algae extract comprises from about 1 to about 30% by weight of the total weight of the composition.
- 24. The method according to claim 23, wherein the red algae extract comprises from about 15 to about 25% by weight of the total weight of the composition.
- 25. The method according to claim 24, wherein the composition further comprises maltodextrins.
- 26. The method according to claim 24, wherein the composition further comprises glycerol.
- 27. The method according to claim 26, wherein the composition further comprises a preservative agent and is subjected to a sterilizing filtration (0.2μ).
- 28. The method according to claim 20, wherein the composition provides from about 10 to about 1000 mg of the extract per administration.
- 29. The method according to claim 20, wherein the composition comprises from about 0.1 to about 5% by weight of the extract.
- 30. The method according to claim 20, wherein the stress protective proteins are selected from the group consisting of HSP60, HSP70 and HSP27.
- 31. The method according to claim 20, wherein the composition is topically or orally administered.
- 32. A method of protecting skin against thermal shock comprising administering a therapeutically effective amount of a composition comprising a water-alcohol extract of red algae that induces synthesis of stress protective proteins in the skin.
- 33. A method of protecting skin against UV radiation comprising administering a therapeutically effective amount of a composition comprising a water-alcohol extract of red algae that induces synthesis of stress protective proteins in the skin.
- 34. A method of protecting skin against infection comprising administering a therapeutically effective amount of a composition comprising a water-alcohol extract of red algae that induces synthesis of stress protective proteins in the skin.
- 35. A method of protecting skin against inflammation comprising administering a therapeutically effective amount of a composition comprising a water-alcohol extract of red algae that induces synthesis of stress protective proteins in the skin.
Priority Claims (2)
| Number |
Date |
Country |
Kind |
| FR 01/14731 |
Nov 2001 |
FR |
|
| FR 02/14253 |
Nov 2002 |
FR |
|
RELATED APPLICATION
[0001] This is a continuation of International Application No. PCT/FRO2/03901, with an international filing date of Nov. 14, 2002 (WO 03/041679, published May 22, 2003), which is based on French Patent Application Nos. 01/14731, filed Nov. 14, 2001, and 02/14253, filed Nov. 11, 2002.
Continuations (1)
|
Number |
Date |
Country |
| Parent |
PCT/FR02/03901 |
Nov 2002 |
US |
| Child |
10844675 |
May 2004 |
US |